Anzatax

OBJECTIVE Low water solubility, high systemic toxicity and insignificant cellular uptake have limited efficient clinical… Expand

Abstract A water-insoluble anti-tumor agent, paclitaxel (PTX) was successfully incorporated into novel-targeted polymeric… Expand

Aerosolized chemotherapeutics leads to higher, localized and continuous concentrations of active agents in lung tissue with lower… Expand

In this study a novel receptor-targeted micelle delivery system based on tocopherol succinate-chitosan-polyethylene glycol-folic… Expand

A simple, rapid, and sensitive reversed-phase HPLC method was developed and validated for determination of paclitaxel (PTX) in… Expand

Objective:To observe the efficacy,tolerance and adverse effect of anzatax and cisplatin combined chemotherapy in the treatment of… Expand

BACKGROUND Paclitaxel is an active agent in the treatment of breast, ovarian, lung and head and neck cancers. In previous phase I… Expand

BACKGROUND Despite its moderate anti-tumour activity in head and neck cancers there have been no reports on the activity of… Expand

To determine the efficacy and safety of paclitaxel given as a three‐hour infusion in patients with metastatic breast cancer which… Expand